Neurofeedback using electroencephalograpy boasts thousands of practitioners and appears to both improve normal brain function and alleviate a wide variety of mental disorders – from anxiety to alcoholism. But after examining the scientific literature and consulting experts in Europe and the U.S., McGill University researchers Robert Thibault and Amir Raz conclude that clinical improvements from this increasingly popular alternative therapy are due to placebo effects.
By the Media Relations Office, McGill Newsroom Spotlight on neurosciences Neuroinformatics stands at the intersection of neuroscience and information science. One of the world leaders in this discipline is Prof. Pedro Valdes-Sosa, General Vice-Director for Research of the Cuban Neuroscience Center (CNEURO) which he co-founded in 1990.
McGill Newsroom The research has implications for understanding human developmental disorders such as autism Adult songbirds modify their vocalizations when singing to juveniles in the same way that humans alter their speech when talking to babies. The resulting brain activity in young birds could shed light on speech learning and certain developmental disorders in humans, according to a study by McGill University researchers.
McGill Newsroom Study of low-, middle-income countries shows increase in minimum wage not always linked to better health Raising the minimum wage in low-and middle-income countries (LMICs) does not necessarily lead to better health for young children, according to a new study by McGill University researchers.
Dr. John Hanrahan, of the Cystic Fibrosis Translational Research Centre (CFTRc) from McGill University, appeared on CTV news to explain that a new treatment for the genetic disease is derived from sea sponges. View the whole interview HERE.
McGill Newsroom Study examines genetic data to analyze regional differences in ancestry A new study of genomic diversity in the U.S. clarifies the role of pre-Civil War admixture and early 20th century transit routes in shaping the migration history and genomic diversity among African-American communities. The research by McGill University professor Simon Gravel and colleagues, was published May 27 in PLOS Genetics.
McGill Newsroom McGill alumnus tagged to boost capacity and discovery in growing field Dr. Robert Platt, Professor in the departments of Pediatrics and Epidemiology, Biostatistics and Occupational Health at McGill University’s Faculty of Medicine was officially announced as the inaugural Albert Boehringer (1st) Chair in Pharmacoepidemiology during an event held May 26 at McGill.
McGill Newsroom Gift expands scholarship program at McGill with $3.5 million gift $3.5 million gift from McGill alumnus and long-time university supporter, Victor Phillip Dahdaleh, will make a major contribution to the field of brain research at the University and provide expanded support to the Victor Dahdaleh-Clinton Foundation Scholarship program.
McGill Newsroom McGill Sociologist uses historical data to provide a new take on an old question
McGill Newsroom Antidepressant use in North America has increased over the last 2 decades. A suspected reason for this trend is that primary care physicians are increasingly prescribing antidepressants for nondepressive indications, including unapproved (off-label) indications that have not been evaluated by regulatory agencies.
By Katherine Gombay, McGill Newsroom Research uncovers the inherently hierarchical nature of social media
McGill Newsroom McGill-led discovery could help fight obesity, metabolic disorders Researchers have uncovered a new molecular pathway for stimulating the body to burn fat – a discovery that could help fight obesity, diabetes and cardiovascular disease.
McGill Newsroom Guidance addresses key scientific, ethical, social, and policy challenges raised by new technologies and emerging areas of stem cell discovery and application
By Shawn Hayward, Montreal Neurological Institute and Hospital Discovery will aid development of treatments for this debilitating disease Scientists at the Montreal Neurological Institute and Hospital (MNI) have identified novel gene mutations that cause hereditary spastic paraplegia (HSP), a step forward in efforts to treat this debilitating disease.
Scientists at the Montreal Neurological Institute and Hospital (MNI) have identified novel gene mutations that cause hereditary spastic paraplegia (HSP), a step forward in efforts to treat this debilitating disease. It is estimated that between two and 10 people per 100,000 in the general population have HSP, a disease characterized by weakness or spasticity in the lower limbs. HSP is caused by mutations inherited from one or both parents.